MedPath

An innovative network-based approach to study and enable well-inFormed dEcision-Making among TurkIsh- and MoroccaN-Dutch women regarding cervIcal caNcer scrEening: the FEMININE study

Conditions
Cervical cancer (baarmoederhalskanker)
Registration Number
NL-OMON20819
Lead Sponsor
ZonMw (nr. 531002030)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
1930
Inclusion Criteria

Turkish-Dutch women aged 30-60 years: women born in Turkey and having at least one parent born in Turkey (first-generation migrants) or women born in the Netherlands and having at least one parent born in Turkey (second-generation migrants).
- Moroccan-Dutch women aged 30-60 years: women born in Morocco and having at least one parent born in Morocco (first-generation migrants) or women born in the Netherlands and having at least one parent born in Morocco (second-generation migrants).

Exclusion Criteria

No Turkish- or Moroccan-Dutch woman aged 30-60 years.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure will be the change in IDM level after receiving the intervention.
Secondary Outcome Measures
NameTimeMethod
Secondary outcome measures will be changes in levels of decision-relevant knowledge, attitude, (intentional) screening participation, and other IDM influencing factors after receiving the intervention. We will also estimate the baseline IDM level using the RDS estimators (if the sociodemographic characteristics stabilise through two consecutive waves, which is in case of a change of less than 2%).
© Copyright 2025. All Rights Reserved by MedPath